1st Day
Regulation and Investment related to Point of Care Diagnostics
Wednesday afternoon, 25th of October 2023
Dear colleagues, dear past and new participants,
Additionally, to the innovation aspects of this symposium, we aim to provide insights on the challenging aspects of regulations (In Vitro Diagnostic Regulation) and investment. Through stakeholders’ feedback and opinions, we bring insights into the compliance with applicable regulations and on the key factors that may trigger a successful investment.
We look forward to meeting you and enjoying an exciting symposium program and good networking!
1st Day | Confirmed Speakers
Latest update: 06.09.2023
Dr. Laura Scrivano
Team Leader | TÜV SÜD Product Service
Title:
POCDx: What is special in the assessment of the design, usability and performance? Lessons learned from the first conformity assessment.
Dr. Andreea Wiese
Head of Partnering for Point of Care | Roche Diagnostics
Round table discussion during the Investment Session
Dr. Vincent Zwaans
COO | Loop Medical SA
Manufacturer’s experience on the search of investment
Round table discussion during the Investment Session
Dr. Iwan Märki
CTO and Co-Founder | Abionic
Manufacturer’s experience on the conformity assessment process under IVDR
Dr. Kim Rochat
Senior Vice President - Regulatory Clinical Quality | Medidee, Veranex
Title:
Interoperability and compatibility: challenges when using POCDx.
Dr. Benjamin Ricken
Head of Point of Care and Self Testing Development | Bühlmann
Introduction and chair of the Investment Session.
More to be announced…
